Coles AJ - Search Results

1

Alemtuzumab for patients with relapsing multiple sclerosis after disease-modifying therapy: a randomised controlled phase 3 trial.

Coles AJ, Twyman CL, Arnold DL, Cohen JA, Confavreux C, Fox EJ, Hartung HP, Havrdova E, Selmaj KW, Weiner HL, Miller T, Fisher E, Sandbrink R, Lake SL, Margolin DH, Oyuela P, Panzara MA, Compston DA; CARE-MS II investigators. Coles AJ, et al. Lancet. 2012 Nov 24;380(9856):1829-39. doi: 10.1016/S0140-6736(12)61768-1. Epub 2012 Nov 1. Lancet. 2012. PMID: 23122650 Clinical Trial.

2

Transient increase in symptoms associated with cytokine release in patients with multiple sclerosis.

Moreau T, Coles A, Wing M, Isaacs J, Hale G, Waldmann H, Compston A. Moreau T, et al. Brain. 1996 Feb;119 ( Pt 1):225-37. doi: 10.1093/brain/119.1.225. Brain. 1996. PMID: 8624684

3

T1 hypointense lesion load in secondary progressive multiple sclerosis: a comparison of pre versus post contrast loads and of manual versus semi automated threshold techniques for lesion segmentation.

O'Riordan JI, Gawne Cain M, Coles A, Wang L, Compston DA, Tofts P, Miller DH. O'Riordan JI, et al. Mult Scler. 1998 Oct;4(5):408-12. doi: 10.1177/135245859800400502. Mult Scler. 1998. PMID: 9839300

4

No association between multiple sclerosis and the Notch3 gene responsible for cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL).

Broadley SA, Sawcer SJ, Chataway SJ, Coraddu F, Coles A, Gray J, Roxburgh R, Clayton D, Compston DA. Broadley SA, et al. J Neurol Neurosurg Psychiatry. 2001 Jul;71(1):97-9. doi: 10.1136/jnnp.71.1.97. J Neurol Neurosurg Psychiatry. 2001. PMID: 11413271 Free PMC article.

5

Multiple sclerosis.

Compston A, Coles A. Compston A, et al. Lancet. 2002 Apr 6;359(9313):1221-31. doi: 10.1016/S0140-6736(02)08220-X. Lancet. 2002. PMID: 11955556 Review.

6

Campath-1H treatment of multiple sclerosis: lessons from the bedside for the bench.

Coles A, Deans J, Compston A. Coles A, et al. Clin Neurol Neurosurg. 2004 Jun;106(3):270-4. doi: 10.1016/j.clineuro.2004.02.013. Clin Neurol Neurosurg. 2004. PMID: 15177782 Clinical Trial. No abstract available.

7

The window of therapeutic opportunity in multiple sclerosis: evidence from monoclonal antibody therapy.

Coles AJ, Cox A, Le Page E, Jones J, Trip SA, Deans J, Seaman S, Miller DH, Hale G, Waldmann H, Compston DA. Coles AJ, et al. J Neurol. 2006 Jan;253(1):98-108. doi: 10.1007/s00415-005-0934-5. Epub 2005 Jul 27. J Neurol. 2006. PMID: 16044212

8

Lymphocyte homeostasis following therapeutic lymphocyte depletion in multiple sclerosis.

Cox AL, Thompson SA, Jones JL, Robertson VH, Hale G, Waldmann H, Compston DA, Coles AJ. Cox AL, et al. Among authors: coles aj. Eur J Immunol. 2005 Nov;35(11):3332-42. doi: 10.1002/eji.200535075. Eur J Immunol. 2005. PMID: 16231285 Free article. Clinical Trial.

9

Campath-1H treatment of multiple sclerosis.

Jones JL, Coles AJ. Jones JL, et al. Among authors: coles aj. Neurodegener Dis. 2008;5(1):27-31. doi: 10.1159/000109935. Neurodegener Dis. 2008. PMID: 18075272 Review.

10

Alemtuzumab vs. interferon beta-1a in early multiple sclerosis.

CAMMS223 Trial Investigators; Coles AJ, Compston DA, Selmaj KW, Lake SL, Moran S, Margolin DH, Norris K, Tandon PK. CAMMS223 Trial Investigators, et al. Among authors: coles aj. N Engl J Med. 2008 Oct 23;359(17):1786-801. doi: 10.1056/NEJMoa0802670. N Engl J Med. 2008. PMID: 18946064 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

167 results

Search Page